A Boom in the Prostate-Cancer Market
The market will surge to $8 billion from $1 billion by decade's end.
Walter Energy Boosted by Trends
The coal miner's contract pricing may be closer to bottoming.
TripAdvisor: A First-Class Stock
Why shares of "the dominant force in the travel review category" could take off.
Stocks in the Spotlight Tuesday
McKesson and Edwards Lifesciences rose. Gentex and RadioShack fell.
Europe Regulation May Be in the Cards
There are expectations for action on debit and credit transactions.
Range Resources Moves Into Neutral Territory
The energy explorer's shares have lost an unmerited takeout premium.
Pfizer Is Right Prescription
The drug maker's shares fell slightly after a disappointing earnings forecast. But we favor the stock over rival Eli Lilly, which also reported.
Oilfield-Service Firms Feel the Pinch
Credit Suisse says margins will be muted in the coming cycle.
Is Sina an Inflated Chinese Stock?
Maxim Group argues that shares of the online media company are still overvalued despite "macro improvement" in China.
Taking the Pulse of Main Street Investors
Individual investors have become more bullish on stocks in recent weeks. Time to sell?
Stocks in the Spotlight Monday
Amylin, Pep Boys, Thomas & Betts and US Airways all rose.
Discounters Hampered by Mild Weather
Off-price retailers saw lower sales of winter apparel and goods.
